A Preliminary Index of SARS-CoV-2 Diagnostic Testing Patents
Petros Gkotsis and
Lesley Potters ()
Additional contact information
Lesley Potters: European Commission - JRC, https://ec.europa.eu/jrc/en
No 2020-07, JRC Working Papers on Corporate R&D and Innovation from Joint Research Centre (Seville site)
Diagnostic testing for COVID-19 is an important part of the management of the current pandemic. In this paper we reason that previous knowledge in diagnostic testing for Coronaviruses (such as MERS-Cov and SARS-Cov) might prove critical to the development and deployment for COVID-19 testing. By extracting keywords from this knowledge, we construct an indicator of inventive activity in the area of Coronavirus diagnostic tests and analyse this over time and measure where this knowledge is located in the world, with potentially important implications for the development and deployment of diagnostics for SARS-CoV-2.
Keywords: diagnostic testing; SARS-CoV2; pandemic; coronavirus; patents; patent analysis (search for similar items in EconPapers)
Pages: 29 pages
New Economics Papers: this item is included in nep-ipr
References: View references in EconPapers View complete reference list from CitEc
Citations: Track citations by RSS feed
Downloads: (external link)
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
Persistent link: https://EconPapers.repec.org/RePEc:ipt:wpaper:202007
Access Statistics for this paper
More papers in JRC Working Papers on Corporate R&D and Innovation from Joint Research Centre (Seville site) Contact information at EDIRC.
Bibliographic data for series maintained by Publication Officer ().